Seth Baum, MD, MASPC, FACC, FAHA, FNLA

Chief Medical Officer, Cardiovascular/Metabolic Lead
Flourish Research

Poster(s):

• (38) Payer analysis of cholesterol management in US individuals with atherosclerotic cardiovascular disease during 2023: A study from the Family Heart Database®
  Wednesday, October 29, 2025

• (41) Olezarsen and plozasiran in the treatment of familial chylomicronemia syndrome (FCS): Results from a matching-adjusted indirect comparison (MAIC)
  Wednesday, October 29, 2025